157 related articles for article (PubMed ID: 9165691)
41. Dosage of intravenous pantoprazole.
Maltz C
Am J Gastroenterol; 2003 Dec; 98(12):2803-5. PubMed ID: 14687838
[No Abstract] [Full Text] [Related]
42. Intermittent intravenous pantoprazole and continuous cimetidine infusion: effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease.
Somberg L; Morris J; Fantus R; Graepel J; Field BG; Lynn R; Karlstadt R
J Trauma; 2008 May; 64(5):1202-10. PubMed ID: 18469642
[TBL] [Abstract][Full Text] [Related]
43. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
44. Pantoprazole treatment does not invoke anti-inflammatory properties in vivo.
Becker TL; Maróstica M; Ribeiro ML; de Mendonça S; Gambero A; Pedrazzoli J
Int Immunopharmacol; 2004 Aug; 4(8):1051-7. PubMed ID: 15222979
[TBL] [Abstract][Full Text] [Related]
45. [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].
Modlin IM
Recenti Prog Med; 2001; 92(7-8):456-61. PubMed ID: 11475787
[TBL] [Abstract][Full Text] [Related]
46. Effect of pantoprazole administered subcutaneously on the healing of sutured gastric incisions in rats.
Bonin EA; Campos AC; Coelho JC; Matias JE; Malafaia O; Jonasson TH
Eur Surg Res; 2005; 37(4):250-6. PubMed ID: 16260877
[TBL] [Abstract][Full Text] [Related]
47. Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers.
Koch HJ; Hartmann M; Bliesath H; Huber R; Steinijans VW; Mascher H; Wurst W
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):420-3. PubMed ID: 8897078
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics and pharmacodynamics of pantoprazole in clinically normal neonatal foals.
Ryan CA; Sanchez LC; Giguère S; Vickroy T
Equine Vet J; 2005 Jul; 37(4):336-41. PubMed ID: 16028623
[TBL] [Abstract][Full Text] [Related]
49. Pharmacodynamics and kinetics of omeprazole MUPS 20 mg and pantoprazole 40 mg during repeated oral administration in Helicobacter pylori-negative subjects.
Geus WP; Mathôt RA; Mulder PG; Lamers CB
Aliment Pharmacol Ther; 2000 Aug; 14(8):1057-64. PubMed ID: 10930900
[TBL] [Abstract][Full Text] [Related]
50. [Acid-supressing capacity of omeprazole 20 mg tablets vs pantoprazole 20 and 40 mg tablets. A pilot study in volunteers].
Corti R; Améndola R; Menéndez G; Diwecj J; Schenone L; Soutric J; Caruso N
Acta Gastroenterol Latinoam; 2003; 33(4):199-203. PubMed ID: 14708472
[TBL] [Abstract][Full Text] [Related]
51. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells.
Yeo M; Kim DK; Kim YB; Oh TY; Lee JE; Cho SW; Kim HC; Hahm KB
Clin Cancer Res; 2004 Dec; 10(24):8687-96. PubMed ID: 15623654
[TBL] [Abstract][Full Text] [Related]
52. Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.
Armstrong D; Bair D; James C; Tanser L; Escobedo S; Nevin K
Aliment Pharmacol Ther; 2003 Oct; 18(7):705-11. PubMed ID: 14510744
[TBL] [Abstract][Full Text] [Related]
53. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ
Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917
[TBL] [Abstract][Full Text] [Related]
54. The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
Postius S; Bräuer U; Kromer W
Life Sci; 1991; 49(14):1047-52. PubMed ID: 1832475
[TBL] [Abstract][Full Text] [Related]
55. Less acid + less bleeding = better outcomes and more money!
Enns R
Can J Gastroenterol; 2004 Dec; 18(12):747-8; discussion 748. PubMed ID: 15605140
[No Abstract] [Full Text] [Related]
56. The acidity index: a simple approach to the measurement of gastric acidity.
Tutuian R; Castell DO; Xue S; Katz PO
Aliment Pharmacol Ther; 2004 Feb; 19(4):443-8. PubMed ID: 14871284
[TBL] [Abstract][Full Text] [Related]
57. Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH.
Müssig S; Witzel L; Lühmann R; Schneider A
Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):599-602. PubMed ID: 9222733
[TBL] [Abstract][Full Text] [Related]
58. The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome.
Tang SJ; Nieto JM; Jensen DM; Ohning GV; Pisegna JR
J Clin Gastroenterol; 2002 Jan; 34(1):62-3. PubMed ID: 11743248
[TBL] [Abstract][Full Text] [Related]
59. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
[TBL] [Abstract][Full Text] [Related]
60. Studies of various administration methods for lansoprazole injection using 24-hour intragastric pH monitoring.
Inoue M; Nakamura M
J Clin Gastroenterol; 1995; 20 Suppl 2():S17-21. PubMed ID: 7594332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
